You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API ranolazine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing ranolazine

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Aphena Pharma Solutions - Tennessee LLC RANEXA ranolazine 43353-880 CARNAUBA WAX
Aphena Pharma Solutions - Tennessee LLC RANEXA ranolazine 43353-880 CELLULOSE, MICROCRYSTALLINE
Aphena Pharma Solutions - Tennessee LLC RANEXA ranolazine 43353-880 FERRIC OXIDE RED
Aphena Pharma Solutions - Tennessee LLC RANEXA ranolazine 43353-880 FERRIC OXIDE YELLOW
Aphena Pharma Solutions - Tennessee LLC RANEXA ranolazine 43353-880 HYPROMELLOSES
Aphena Pharma Solutions - Tennessee LLC RANEXA ranolazine 43353-880 MAGNESIUM STEARATE
Aphena Pharma Solutions - Tennessee LLC RANEXA ranolazine 43353-880 METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing ranolazine

Company Ingredient NDC Excipient
Ajanta Pharma USA Inc ranolazine 27241-125 CELLULOSE, MICROCRYSTALLINE
Ajanta Pharma USA Inc ranolazine 27241-125 FERRIC OXIDE RED
Ajanta Pharma USA Inc ranolazine 27241-125 FERRIC OXIDE YELLOW
Ajanta Pharma USA Inc ranolazine 27241-125 HYPROMELLOSE
Ajanta Pharma USA Inc ranolazine 27241-125 MAGNESIUM STEARATE
Ajanta Pharma USA Inc ranolazine 27241-125 METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
Ajanta Pharma USA Inc ranolazine 27241-125 POLYETHYLENE GLYCOL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for ranolazine

Excipient focus: ALUMINUM OXIDE

Excipient focus: CARMINIC ACID

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DIBUTYL SEBACATE

Excipient focus: DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

ranolazine drug variants not containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

Company Ingredient NDC
Ajanta Pharma USA Inc ranolazine 27241-125
Unichem Pharmaceuticals (USA) Inc ranolazine 29300-296
Camber Pharmaceuticals Inc ranolazine 31722-668
AvKARE ranolazine 42291-773
Laurus Generics Inc ranolazine 42385-963
Micro Labs Limited ranolazine 42571-324
Aphena Pharma Solutions - Tennessee LLC ranolazine 43353-880
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: ETHYLCELLULOSE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

ranolazine drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Company Ingredient NDC
Ajanta Pharma USA Inc ranolazine 27241-125
Camber Pharmaceuticals Inc ranolazine 31722-668
AvKARE ranolazine 42291-773
Laurus Generics Inc ranolazine 42385-963
Aphena Pharma Solutions - Tennessee LLC ranolazine 43353-880
ANI Pharmaceuticals Inc ranolazine 43975-290
SUN PHARMACEUTICAL INDUSTRIES INC ranolazine 47335-624
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

ranolazine drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

Company Ingredient NDC
Ajanta Pharma USA Inc ranolazine 27241-125
Unichem Pharmaceuticals (USA) Inc ranolazine 29300-296
Camber Pharmaceuticals Inc ranolazine 31722-668
AvKARE ranolazine 42291-773
Laurus Generics Inc ranolazine 42385-963
Micro Labs Limited ranolazine 42571-324
Aphena Pharma Solutions - Tennessee LLC ranolazine 43353-880
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

ranolazine drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Company Ingredient NDC
Ajanta Pharma USA Inc ranolazine 27241-125
Camber Pharmaceuticals Inc ranolazine 31722-668
AvKARE ranolazine 42291-773
Laurus Generics Inc ranolazine 42385-963
Aphena Pharma Solutions - Tennessee LLC ranolazine 43353-880
ANI Pharmaceuticals Inc ranolazine 43975-290
SUN PHARMACEUTICAL INDUSTRIES INC ranolazine 47335-624
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: PEG-10 COCAMINE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM ALGINATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group